Latest Insider Transactions at Hillstream Bio Pharma Inc. (HILS)
This section provides a real-time view of insider transactions for Hillstream Bio Pharma Inc. (HILS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hillstream BioPharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hillstream BioPharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2024
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
4,600
+20.78%
|
$9,200
$2.12 P/Share
|
|
Nov 13
2024
|
Sireesh Appajosyula Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+31.73%
|
$10,000
$2.02 P/Share
|
|
Oct 08
2024
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+6.24%
|
$5,000
$2.09 P/Share
|
|
Oct 08
2024
|
Sireesh Appajosyula Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+23.4%
|
$5,000
$1.93 P/Share
|
|
Dec 15
2023
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
29,000
+15.63%
|
$0
$0.5 P/Share
|
|
Nov 30
2023
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+7.27%
|
$10,000
$1.0 P/Share
|
|
Jul 14
2022
|
Sireesh Appajosyula Chief Operating Officer |
BUY
Bona fide gift
|
Indirect |
7,576
+50.0%
|
-
|
|
Jul 14
2022
|
Sireesh Appajosyula Chief Operating Officer |
SELL
Bona fide gift
|
Indirect |
75,757
-100.0%
|
-
|
|
Jun 17
2022
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$0
$0.78 P/Share
|
|
Jun 06
2022
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.01%
|
$0
$0.68 P/Share
|
|
Jun 01
2022
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
1
|
$0
$0.94 P/Share
|
|
May 25
2022
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$0
$0.78 P/Share
|
|
May 20
2022
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$0
$0.92 P/Share
|
|
May 19
2022
|
Randy Milby CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.02%
|
$0
$0.91 P/Share
|
|
Apr 18
2022
|
Randy Milby CEO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
240,526
+1.58%
|
$0
$0.22 P/Share
|
|
Jan 14
2022
|
Randy Milby CEO |
BUY
Conversion of derivative security
|
Direct |
921,288
+0.94%
|
$2,763,864
$3.2 P/Share
|
|
Jan 14
2022
|
Leonard L Mazur Director |
BUY
Open market or private purchase
|
Direct |
25,000
+16.81%
|
$100,000
$4.0 P/Share
|
|
Jan 14
2022
|
Leonard L Mazur Director |
BUY
Conversion of derivative security
|
Direct |
98,733
+50.0%
|
$296,199
$3.2 P/Share
|